Correlation Between Madrigal Pharmaceuticals and Alto Neuroscience,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Alto Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Alto Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Alto Neuroscience,, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Alto Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Alto Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Alto Neuroscience,.

Diversification Opportunities for Madrigal Pharmaceuticals and Alto Neuroscience,

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Madrigal and Alto is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Alto Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alto Neuroscience, and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Alto Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alto Neuroscience, has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Alto Neuroscience, go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Alto Neuroscience,

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.51 times less return on investment than Alto Neuroscience,. In addition to that, Madrigal Pharmaceuticals is 1.21 times more volatile than Alto Neuroscience,. It trades about 0.08 of its total potential returns per unit of risk. Alto Neuroscience, is currently generating about 0.14 per unit of volatility. If you would invest  431.00  in Alto Neuroscience, on October 28, 2024 and sell it today you would earn a total of  39.00  from holding Alto Neuroscience, or generate 9.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Alto Neuroscience,

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Alto Neuroscience, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Alto Neuroscience, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Alto Neuroscience, displayed solid returns over the last few months and may actually be approaching a breakup point.

Madrigal Pharmaceuticals and Alto Neuroscience, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Alto Neuroscience,

The main advantage of trading using opposite Madrigal Pharmaceuticals and Alto Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Alto Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will offset losses from the drop in Alto Neuroscience,'s long position.
The idea behind Madrigal Pharmaceuticals and Alto Neuroscience, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes